Irving, Texas (PRWEB) February 28, 2013
The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5.7%. The fragmented market has observed some changes in the competitive landscape during the last five years. The top players are expanding their footprints in the emerging markets of China, India, Brazil, Latin America, and Eastern Europe. They are strengthening their technological and R&D structure by targeted merger and acquisition activities to help develop and market innovative drugs.
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis on the global drugs industry and presents its findings in “Top Five Global Pharmaceutical Companies: Trend, Profit, and Forecast Analysis.” This report briefly discusses the subject companies, their geographic footprints, financial metrics, market performance, marketing and corporate strategies, and provides SWOT analysis of each.
The medical market report indicates that increased regulation of the pharmaceutical industry is expected to increase the industry’s cost structure and reduce revenue as getting drugs to market becomes a longer and more expensive process. Regulatory approval for the introduction of biogenerics/biosimilars, generic versions of biologic drugs, increases the threat of uncertainty to the pharmaceutical market.
Lucintel projects the major drivers of the industry. Growth in sectors such as health awareness among populations, R&D expenditures, sales of prescribed medicine, and demand for generic medicines are expect to continue to provide huge demand for medicines. Various governments’ increased spending in infectious and chronic degenerative diseases as well as anti-diabetes and cardiovascular drugs have driven the growth in sales of the pharmaceutical industry.
The report gives an overview of the top five global pharmaceutical companies:
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Roche Holding Ltd
The industry witnessed increasing awareness and affordability of patients who prefer self-diagnosis and treatment at home.
For a detailed table of contents and pricing information on this timely, insightful report, contact Lucintel at +1-972-636-5056 or via email at helpdesk(at)lucintel(dot)com. Lucintel provides cutting-edge decision support services that facilitate critical decisions with greater speed, insight, strategic growth consulting, and cost efficiency. To learn more, visit http://www.lucintel.com.
Lucintel now offers free Live Chat on its website to answer visitors’ questions in real time with precision. Visitors can directly chat with our experts through Live Chat to receive assistance and information regarding Lucintel’s product and service offerings.
Lucintel a Free Webinar, “Growth Opportunities in Solar Photovoltaic Market 2012-2017,” on 7th March , 2013. Please click here for webinar registration